WCMNY
STJ

Westchester Capital Management (New York)’s St Jude Medical STJ Stock Holding History

Westchester Capital Management (New York)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,816,119
Closed -$146M – 122
2016
Q4 		$146M Sell
1,816,119
-2,859
-0.2% -$227K 3.68% 2
2016
Q3 		$145M Buy
1,818,978
+315,061
+21% +$25.4M 4.15% 6
2016
Q2 		$117M Buy
+1,503,917
New +$107M 2.69% 12

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Westchester Capital Management (New York)'s STJ Position: Q1 2017 in Review

Westchester Capital Management (New York) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,816,119 shares — an estimated $146M sold.

Westchester Capital Management (New York) first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $146M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Westchester Capital Management (New York) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 1,816,119 St Jude Medical shares in Q1 2017, an estimated $146M.
  • Westchester Capital Management (New York) first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Westchester Capital Management (New York)'s St Jude Medical position peaked at $146M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2017, filed 15 May 2017.